Review
Published on 22 Jul 2024
An overview of traditional smoking cessation interventions and E-cigarettes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1293062
- 1,684 views
Type at least 3 characters
1,947 articles
Articles
Original Research
Published on 19 Jul 2024
Cost-effectiveness analysis of pharmaceutical care in adult critically ill patients: based on a prospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446834
- 1,100 views
Systematic Review
Published on 18 Jul 2024
Uptake of evidence-based practice and its predictors among nurses in Ethiopia: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421690
- 1,279 views
- 1 citation
Editorial
Published on 16 Jul 2024
Editorial: Building the clinical research workforce: challenges, capacities and competencies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446908
- 685 views
Original Research
Published on 16 Jul 2024
Management of drug supply chain information based on “artificial intelligence + vendor managed inventory” in China: perspective based on a case study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373642
- 6,506 views
- 1 citation
Original Research
Published on 16 Jul 2024
Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1417596
- 1,649 views
Original Research
Published on 15 Jul 2024
Preemptive oral analgesia with steroidal and nonsteroidal anti-inflammatory drugs in periodontal surgery: a systematic review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385401
- 796 views
Original Research
Published on 12 Jul 2024
The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1382120
- 1,090 views
Original Research
Published on 12 Jul 2024
Cost-effectiveness analysis of camrelizumab plus paclitaxel and carboplatin versus sintilimab plus gemcitabine and cisplatin or carboplatin for the first-line treatment of local advanced or metastatic squamous NSCLC in Chinese mainland
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1356725
- 802 views
Brief Research Report
Published on 12 Jul 2024
Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1370040
- 858 views
Original Research
Published on 11 Jul 2024
Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1303808
- 688 views
Original Research
Published on 10 Jul 2024
Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1420478
- 1,678 views
Original Research
Published on 10 Jul 2024
Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1385651
- 1,748 views
Original Research
Published on 08 Jul 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416985
- 2,722 views
- 1 citation
Original Research
Published on 05 Jul 2024
A point prevalence survey and monitoring indicator research on the second batch of national key monitoring and rational use drugs
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1416010
- 590 views
Original Research
Published on 02 Jul 2024
Patient preferences for generic substitution policies: a discrete choice experiment in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1400156
- 866 views